title: Usefulness of tissue microarrays for assessment of protein expression, gene copy number and mutational status of EGFR in lung adenocarcinoma.
abstract: Specific inhibitors targeting the epidermal growth factor receptor (EGFR) can increase survival rates in certain lung adenocarcinoma patients with mutations in the EGFR gene. Although such EGFR-targeted therapies have been approved for use, there is no general consensus among surgical pathologists on how the EGFR status should be tested in lung adenocarcinoma tissues and whether the results of immunohistochemistry (IHC), fluorescence in situ hybridization (FISH), and mutational analysis by molecular methods correlate. We evaluated the EGFR status in 61 lung adenocarcinomas by IHC (using total and mutant-specific antibodies against EGFR), by FISH analysis on tissue microarrays (TMAs), and by direct sequencing. The results of each method were compared using χ² and κappa statistics. The sensitivity and negative predictive value estimating the presence of abnormal EGFR for each test was calculated. The results show that, with respect to expression patterns and clinicopathological parameters, the total and mutant-specific EGFR detected by immunohistochemistry and FISH analysis on TMAs are valid and are equivalent to conventional methods performed on whole-tissue sections. Abnormal EGFR was detected in 52.4% of patients by IHC, FISH, and sequencing. The best sensitivity (100%) and negative predictive value (100%) was determined by evaluating the EGFR status with all methods. Testing for molecular changes in EGFR using a single test is likely to underestimate the presence of EGFR abnormalities. Taken together, these results demonstrate the high potential of TMAs to test for the major mechanisms of EGFR activation in patients with lung adenocarcinoma.
authors.affiliation: Laboratory of Clinical and Experimental Pathology, Louis Pasteur Hospital, 06002 Nice Cedex 01, France.
authors.forename: Marius I
authors.initials: MI
authors.lastname: Ilie
authors.forename: Véronique
authors.initials: V
authors.lastname: Hofman
authors.forename: Christelle
authors.initials: C
authors.lastname: Bonnetaud
authors.forename: Katia
authors.initials: K
authors.lastname: Havet
authors.forename: Virginie
authors.initials: V
authors.lastname: Lespinet-Fabre
authors.forename: Céline
authors.initials: C
authors.lastname: Coëlle
authors.forename: Virginie
authors.initials: V
authors.lastname: Gavric-Tanga
authors.forename: Nicolas
authors.initials: N
authors.lastname: Vénissac
authors.forename: Jerôme
authors.initials: J
authors.lastname: Mouroux
authors.forename: Paul
authors.initials: P
authors.lastname: Hofman
mesh_terms: D000230:Adenocarcinoma / Q000737:chemistry* / Q000235:genetics; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D066246:ErbB Receptors / Q000032:analysis* / Q000235:genetics; D005260:Female; D018628:Gene Dosage; D006801:Humans; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D008175:Lung Neoplasms / Q000737:chemistry* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009154:Mutation; D046888:Tissue Array Analysis / Q000379:methods*
chemical_list: D066246:ErbB Receptors
references.citation: J Clin Oncol. 2005 Apr 10;23(11):2493-501
references.pmid: 15710947
references.citation: J Clin Oncol. 2003 Jul 15;21(14):2787-99
references.pmid: 12860957
references.citation: Mol Cell Proteomics. 2008 Oct;7(10):1902-24
references.pmid: 18687633
references.citation: Int J Cancer. 2001 Oct 1;94(1):1-5
references.pmid: 11668471
references.citation: Mod Pathol. 2009 Jan;22(1):128-33
references.pmid: 18997733
references.citation: Ann Oncol. 2007 Apr;18(4):752-60
references.pmid: 17317677
references.citation: Clin Cancer Res. 2009 May 1;15(9):3023-8
references.pmid: 19366827
references.citation: Clin Cancer Res. 2001 Jul;7(7):1850-5
references.pmid: 11448895
references.citation: Curr Oncol. 2009 Jan;16(1):27-48
references.pmid: 19229369
references.citation: N Engl J Med. 2009 Sep 3;361(10):947-57
references.pmid: 19692680
references.citation: Clin Cancer Res. 2006 Dec 15;12(24):7242-51
references.pmid: 17189395
references.citation: Br J Cancer. 2008 Mar 11;98(5):956-64
references.pmid: 18268492
references.citation: Cancer. 2005 Mar 15;103(6):1265-73
references.pmid: 15712203
references.citation: J Pathol. 2001 Sep;195(1):72-9
references.pmid: 11568893
references.citation: J Mol Diagn. 2010 Mar;12(2):169-76
references.pmid: 20093391
references.citation: Nat Clin Pract Oncol. 2006 Jan;3(1):50-7; quiz 1 p following 57
references.pmid: 16407879
references.citation: J Clin Oncol. 2008 Feb 20;26(6):983-94
references.pmid: 18281673
references.citation: Semin Oncol. 2002 Feb;29(1 Suppl 4):3-14
references.pmid: 11894009
references.citation: Curr Opin Oncol. 2005 Mar;17(2):118-22
references.pmid: 15725915
references.citation: Expert Rev Anticancer Ther. 2009 Apr;9(4):401-12
references.pmid: 19374595
references.citation: Diagn Mol Pathol. 2009 Sep;18(3):133-7
references.pmid: 19704257
references.citation: Clin Cancer Res. 2009 Jul 1;15(13):4493-8
references.pmid: 19531624
references.citation: Ann Pathol. 2010 Apr;30(2):85-93
references.pmid: 20451063
references.citation: Cancer. 2007 May 1;109(9):1836-44
references.pmid: 17387741
references.citation: J Mol Diagn. 2008 May;10(3):242-8
references.pmid: 18403609
references.citation: N Engl J Med. 2008 Mar 13;358(11):1160-74
references.pmid: 18337605
references.citation: Annu Rev Med. 2008;59:429-42
references.pmid: 17716025
references.citation: Diagn Mol Pathol. 2004 Dec;13(4):213-6
references.pmid: 15538111
references.citation: J Cancer Res Clin Oncol. 2005 Mar;131(3):199-203
references.pmid: 15592685
references.citation: J Clin Oncol. 2006 Nov 1;24(31):5034-42
references.pmid: 17075123
references.citation: J Clin Oncol. 2005 Nov 1;23(31):8081-92
references.pmid: 16204011
references.citation: Arch Pathol Lab Med. 2008 Oct;132(10):1635-47
references.pmid: 18834223
references.citation: BMC Cancer. 2009 Jan 07;9:6
references.pmid: 19128465
references.citation: Br J Cancer. 2010 May 25;102(11):1627-35
references.pmid: 20461082
references.citation: Nat Rev Cancer. 2007 Mar;7(3):169-81
references.pmid: 17318210
references.citation: J Clin Oncol. 2005 Apr 10;23(11):2513-20
references.pmid: 15738541
references.citation: Chest. 1997 Jun;111(6):1710-7
references.pmid: 9187198
references.citation: Cancer Res. 2004 Dec 1;64(23):8534-40
references.pmid: 15574759
references.citation: J Clin Oncol. 2005 Oct 1;23(28):6838-45
references.pmid: 15998906
references.citation: World J Gastrointest Oncol. 2010 Jan 15;2(1):5-8
references.pmid: 21160810
references.citation: Thyroid. 2009 Nov;19(11):1239-48
references.pmid: 19888862
references.citation: Thorax. 2006 Feb;61(2):140-5
references.pmid: 16284218
references.citation: N Engl J Med. 2008 Sep 25;359(13):1367-80
references.pmid: 18815398
references.citation: J Clin Oncol. 2004 Aug 15;22(16):3238-47
references.pmid: 15310767
references.citation: N Engl J Med. 2005 Jul 14;353(2):133-44
references.pmid: 16014883
references.citation: J Mol Diagn. 2008 Mar;10(2):160-8
references.pmid: 18258923
references.citation: J Thorac Oncol. 2007 Apr;2(4):327-43
references.pmid: 17409807
references.citation: Nat Rev Drug Discov. 2003 Dec;2(12):962-72
references.pmid: 14654795
references.citation: Br J Cancer. 2004 Jul 19;91(2):208-12
references.pmid: 15187994
references.citation: Pediatr Blood Cancer. 2009 Feb;52(2):209-14
references.pmid: 19006223
references.citation: J Cancer Res Clin Oncol. 2008 May;134(5):569-77
references.pmid: 17932690
references.citation: Hum Pathol. 2009 Mar;40(3):356-65
references.pmid: 18976796
references.citation: Eur J Surg Oncol. 2007 Oct;33(8):956-60
references.pmid: 17374474
references.citation: Exp Cell Res. 2003 Mar 10;284(1):31-53
references.pmid: 12648464
references.citation: J Clin Oncol. 2003 Oct 15;21(20):3798-807
references.pmid: 12953099
references.citation: J Natl Cancer Inst. 2005 May 4;97(9):643-55
references.pmid: 15870435
references.citation: Cancer Epidemiol Biomarkers Prev. 2010 Apr;19(4):1004-11
references.pmid: 20332280
references.citation: Br J Cancer. 2007 Mar 26;96(6):857-63
references.pmid: 17325698